Moxicum 400 mg/250 ml soluţie perfuzabilă Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

moxicum 400 mg/250 ml soluţie perfuzabilă

world medicine ilac san.ve tic. a.Ș. - moxifloxacinum - soluţie perfuzabilă - 400 mg/250 ml

Bivoxa 5 mg/ml picături oftalmice, soluţie Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bivoxa 5 mg/ml picături oftalmice, soluţie

world medicine ilac san.ve tic. a.Ș. - moxifloxacinum - picături oftalmice, soluţie - 5 mg/ml

Scemblix Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - leucemie, mielogenă, cronică, bcr-abl pozitivă - agenți antineoplazici - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Vanflyta Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

vanflyta

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemie mieloidă - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Sorbifer  Durules 320 mg + 60 mg comprimate filmate Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sorbifer durules 320 mg + 60 mg comprimate filmate

egis pharmaceuticals plc - ferrosi sulfas + acid ascorbicum - comprimate filmate - 320 mg + 60 mg